Shuangyan Ou

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Josep M. Llovet, Masatoshi Kudo, Philippe Merle et al. · The Lancet Oncology · 2023 · 421 citations · Full text

Medicine, Oncology, Pharmacology +12

Adipose-derived exosomes deliver miR-23a/b to regulate tumor growth in hepatocellular cancer by targeting the VHL/HIF axis

Yang Liu, Juan Tan, Shuangyan Ou et al. · Journal of Physiology and Biochemistry · 2019 · 99 citations

Life Sciences, Molecular Biology, Oncology +17

Evidence for altered hippocampal volume and brain metabolites in workers occupationally exposed to lead: A study by magnetic resonance imaging and 1H magnetic resonance spectroscopy

Yue‐Ming Jiang, Liling Long, X ZHU et al. · Toxicology Letters · 2008 · 54 citations · Full text

Pharmacy, Neuroscience, Toxicology +17

m6A Methyltransferase METTL14-Mediated Upregulation of Cytidine Deaminase Promoting Gemcitabine Resistance in Pancreatic Cancer

Congjun Zhang, Shuangyan Ou, Yuan Zhou et al. · Frontiers in Oncology · 2021 · 42 citations · Full text

Medicine, Molecular Biology, Oncology +16

The spread of metastatic lymph nodes to the mediastinum from left upper lobe cancer: results of superior mediastinal nodal dissection through a median sternotomy

Yukinori Sakao, Hideaki Miyamoto, Asako YAMAZAKI et al. · European Journal of Cardio-Thoracic Surgery · 2006 · 27 citations · Full text

Medicine, Oncology, Surgery +16